Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment

By afschroeder • October 6, 2025

Fava A, Wagner CA, Guthridge CJ, Macwana S, DeJager W, Munroe ME, Izmirly P, Belmont HM, Diamond B, Davidson A, Utz PJ, Weisman MH, Carlucci PM, Dall'Era M, Kalunian K, Putterman C, Anolik J, Barnas JL, Wofsy D, Kamen D, Furie RA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network; Petri M, Guthridge JM, Buyon J, James JA. Serum soluble mediator signatures of lupus nephritis: histological features and response to treatment. Arthritis Care Res (Hoboken). 2025 Oct 6. doi: 10.1002/acr.25652. Epub ahead of print. PMID: 41048053.

Tags: Cedars Sinai DoM, Publications, Rheumatology

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry

Hijazi W, Zhou J, Miller RJH, Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Kavanagh PB, Parekh T, Liang JX, Alexanderson E, Carvajal-Juarez I, Slipczuk[...]

Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study

Naeim A, Cheng J, Spiegel B, Bakshian A, Tetrault E, Mehra M, Amini D, Krut Z, Shang H, Sedrak MS, Bui A, Johnson T, Wang[...]

Evaluating associations of oxylipin metabolites and fatty acids with incident and prevalent type 2 diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Downie CG, Highland HM, Howard AG, Alotaibi M, Elfassy T, Cordero C, Below JE, Carnethon M, Cheng S, Daviglus M, Garcia-Bedoya O, Kaplan R, Khambaty[...]